WFIKKN2 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8TEU8 |
---|---|
Clone Names | 100406270 |
Gene ID | 124857 |
---|---|
Other Names | WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2, Growth and differentiation factor-associated serum protein 1, GASP-1, hGASP-1, WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing-related protein, WFIKKN-related protein, WFIKKN2, GASP1, WFIKKNRP |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | WFIKKN2 |
---|---|
Synonyms | GASP1, WFIKKNRP |
Function | Protease-inhibitor that contains multiple distinct protease inhibitor domains. Probably has serine protease- and metalloprotease- inhibitor activity. Inhibits the biological activity of mature myostatin, but not activin (By similarity). |
Cellular Location | Secreted. |
Tissue Location | Primarily expressed in ovary, testis and brain, but not in liver. In fetal tissues, it is primarily expressed in brain, skeletal muscle, thymus and kidney. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The WFIKKN1 protein contains a WAP domain, follistatindomain, immunoglobulin domain, two tandem Kunitz domains, and anNTR domain. This gene encodes a WFIKKN1-related protein which hasthe same domain organization as the WFIKKN1 protein. The WAP-type,follistatin type, Kunitz-type, and NTR-type protease inhibitorydomains may control the action of multiple types of proteases.
References
Saremi, A., et al. Mol. Cell. Endocrinol. 317 (1-2), 25-30 (2010) :Kondas, K., et al. J. Biol. Chem. 283(35):23677-23684(2008)Clark, H.F., et al. Genome Res. 13(10):2265-2270(2003)Hill, J.J., et al. Mol. Endocrinol. 17(6):1144-1154(2003)Nagy, A., et al. Eur. J. Biochem. 270(9):2101-2107(2003)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.